Earnings Preview: AVITA Medical
Portfolio Pulse from Benzinga Insights
AVITA Medical (NASDAQ:RCEL) is scheduled to release its quarterly earnings report on February 22, 2024. Analysts predict an EPS of $-0.37. The company's past earnings performance shows a mixed impact on its stock price, with significant fluctuations following earnings announcements. Shares of AVITA Medical have increased by 87.97% over the last 52 weeks, trading at $17.58 as of February 20. Investors are looking for a beat on the estimated EPS and positive guidance for future growth.
February 21, 2024 | 6:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
AVITA Medical is anticipated to report an EPS of $-0.37 for the latest quarter. Historical data shows its stock price can significantly fluctuate post-earnings. With a 87.97% increase in share price over the last year, investors are optimistic.
Given AVITA Medical's history of stock price volatility post-earnings and the significant year-over-year share price increase, the upcoming earnings report is highly relevant and important to investors. The positive long-term performance may indicate investor optimism, suggesting a potential positive short-term impact on RCEL's stock price if the company beats the EPS estimate and provides favorable future guidance.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100